Name | BCR-ABL-IN-1 |
---|
Description | BCR-ABL-IN-1 is an inhibitor of BCR-ABL tyrosine kinase, with a pIC50 of 6.46, and may be used in the research of chronic myelogenous leukemia. |
---|---|
Related Catalog | |
Target |
pIC50: 6.46 (BCR-ABL)[1] |
In Vitro | BCR-ABL-IN-1 (Compound 21) is an inhibitor of BCR-ABL tyrosine kinase, with a pIC50 of 6.46, and may be used in the research of chronic myelogenous leukemia. |
References |
Molecular Formula | C23H21F4N5O |
---|---|
Molecular Weight | 459.44 |
Storage condition | 2-8℃ |